Bioequivalence Study of Two Treatments for the Treatment of Plaque Psoriasis

Status:
Recruiting

Trial end date:
2024-09-30

Target enrollment:

Participant gender:

To compare the safety and efficacy of Padagis' product to an FDA approved product for the treatment of plaque psoriasis

Phase 3

Padagis LLC